Moreover, when comparing TAGs from the mature GBM phenotypes to TAGs from non-angiogenic gliomas, we observed a significant upregulation of Vegf, Angiopoietin 2 and Fgf2 (Fig. 4c). This evidence concerns the gene ANGPT2 and central nervous system cancer.